Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Express Scripts
Merck
Medtronic
Baxter

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

Strides Pharma Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for STRIDES PHARMA, and what generic and branded alternatives to STRIDES PHARMA drugs are available?

STRIDES PHARMA has sixty-eight approved drugs.

There are four tentative approvals on STRIDES PHARMA drugs.

Summary for Strides Pharma
US Patents:0
Tradenames:54
Ingredients:54
NDAs:68
Patent Litigation for Strides Pharma: See patent lawsuits for Strides Pharma

Drugs and US Patents for Strides Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Strides Pharma IBUPROFEN ibuprofen TABLET;ORAL 078329-001 Feb 5, 2009 AB RX No No   Start Trial   Start Trial
Strides Pharma ACETAZOLAMIDE acetazolamide TABLET;ORAL 209734-001 Nov 20, 2017 AB RX No No   Start Trial   Start Trial
Strides Pharma AMLODIPINE BESYLATE amlodipine besylate TABLET;ORAL 077516-001 Jul 11, 2007 AB RX No No   Start Trial   Start Trial
Strides Pharma IBUPROFEN ibuprofen TABLET;ORAL 078329-002 Feb 5, 2009 AB RX No No   Start Trial   Start Trial
Strides Pharma IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE diphenhydramine hydrochloride; ibuprofen CAPSULE;ORAL 200888-001 Mar 5, 2012 OTC No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Express Scripts
Boehringer Ingelheim
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.